AcuityMD now supports more than 200 MedTech companies, including leaders BD and SI-Bone
Read Story »AcuityMD today announced $45 million in new funding to expand its commercial intelligence platform and advance the company’s mission of accelerating adoption of cutting-edge medical technology (MedTech).
Read Story »AcuityMD’s platform helps emerging MedTech company solve commercialization challenges
Read Story »AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, announced that Intellijoint Surgical, developer of surgical planning and navigation solutions for total hip and knee joint replacements, will leverage its platform to identify new business prospects, manage pipeline, and scale operations. Intellijoint’s easy-to-use devices are used by leading orthopedic surgeons globally.
Read Story »AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, announced the launch of Pipeline, a new module that enables sales representatives to execute on prospects throughout the sales lifecycle, track progress, forecast accurately, and ultimately improve business planning to grow revenue.
Read Story »BOSTON — September 12, 2023 —AcuityMD, provider of a novel commercial platform for medical technology (MedTech) companies, has expanded its partnership with Olympus Corporation, a top 20 MedTech company that delivers advanced diagnostic, therapeutic, and minimally invasive procedures to healthcare professionals (HCPs).
Read Story »AcuityMD’s data-driven commercial platform has helped device innovators identify more than 60,000 untapped healthcare professionals and over $6 billion in opportunity value.
Read Story »FEMSelect, an Israeli-based MedTech startup, partners with AcuityMD to accelerate identification and engagement of U.S. physicians treating pelvic floor disorders (PFD).
Read Story »New data-driven, commercial platform for medical technology companies fills market need in a fast-growing industry, forecasted CAGR of 5.5% through 2029
Read Story »AcuityMD accelerates widespread market access to novel opioid withdrawal treatment device, currently in use across 24 U.S. rehabilitation facilities
Read Story »Today we’re excited to share that AcuityMD has raised $31M in Series A funding led by Redpoint Venture Partners, with support from Benchmark, the leader of our seed round, as well as Ajax Health and Artisanal Ventures.
Read Story »AcuityMD enables Dilon to quickly identify the right doctors and medical facilities in urgent need of its life-saving medical technology
Read Story »